HIV Post Exposure Prophylaxis: prospects, opportunities and challenges.
作者信息
Fox Julie, Sibanda Euphemia L, Godfrey-Faussett Peter
机构信息
King's College London, London, UK.
Guys and St Thomas's NHS Foundation Trust, London, UK.
出版信息
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26511. doi: 10.1002/jia2.26511.
Abstract
摘要
相似文献
1
HIV Post Exposure Prophylaxis: prospects, opportunities and challenges.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26511. doi: 10.1002/jia2.26511.
2
Research designs to generate evidence of HIV post-exposure prophylaxis effectiveness for new long-acting agents.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26475. doi: 10.1002/jia2.26475.
3
Navigating Barriers and Opportunities: Perceptions of the Non-Occupational Post-Exposure Prophylaxis Care Continuum Among Young Sexual Minority Men, Aged 17-24, in the United States.
AIDS Patient Care STDS. 2024 Jun;38(6):267-274. doi: 10.1089/apc.2024.0012. Epub 2024 Jun 12.
4
Poor post-exposure prophylaxis completion despite improvements in post-violence service delivery in 14 PEPFAR-supported sub-Saharan African countries, 2018-2023.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26469. doi: 10.1002/jia2.26469.
5
Limited awareness and use of HIV post-exposure prophylaxis among people vulnerable to HIV acquisition in Western Kenya: a cross-sectional analysis.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26472. doi: 10.1002/jia2.26472.
6
Modelling the impact of initiation delay, duration and prior PrEP on the efficacy of post-exposure prophylaxis containing a tenofovir/emtricitabine backbone.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26454. doi: 10.1002/jia2.26454.
7
Untapped potential of post-exposure prophylaxis in sub-Saharan Africa: a comparative analysis of PEP implementation planning in Kenya, Mozambique, Nigeria, Uganda and Zambia.
J Int AIDS Soc. 2025 Jun;28 Suppl 1:e26471. doi: 10.1002/jia2.26471.
8
Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review.
J Int AIDS Soc. 2021 Feb;24(2):e25673. doi: 10.1002/jia2.25673.
9
Online delivery of oral HIV pre- and post-exposure prophylaxis: findings from the ePrEP Kenya pilot.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26468. doi: 10.1002/jia2.26468.
10
A modified pharmacy provider-led delivery model of oral HIV pre- and post-exposure prophylaxis in Kenya: a pilot study extension.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26467. doi: 10.1002/jia2.26467.
本文引用的文献
1
Research designs to generate evidence of HIV post-exposure prophylaxis effectiveness for new long-acting agents.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26475. doi: 10.1002/jia2.26475.
2
Healthcare provider recommendations to improve post-violence care HIV post-exposure prophylaxis access and adherence in Mozambique.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26452. doi: 10.1002/jia2.26452.
3
Poor post-exposure prophylaxis completion despite improvements in post-violence service delivery in 14 PEPFAR-supported sub-Saharan African countries, 2018-2023.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26469. doi: 10.1002/jia2.26469.
4
Limited awareness and use of HIV post-exposure prophylaxis among people vulnerable to HIV acquisition in Western Kenya: a cross-sectional analysis.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26472. doi: 10.1002/jia2.26472.
5
Developing and evaluating a community-driven intervention to promote uptake of HIV and contraception services among students enrolled in colleges and universities in Zimbabwe.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26461. doi: 10.1002/jia2.26461.
6
Modelling the impact of initiation delay, duration and prior PrEP on the efficacy of post-exposure prophylaxis containing a tenofovir/emtricitabine backbone.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26454. doi: 10.1002/jia2.26454.
7
Characteristics of individuals who received post-exposure prophylaxis and HIV seroconversion in Malawi: an analysis of national routine HIV testing data.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26473. doi: 10.1002/jia2.26473.
8
A modified pharmacy provider-led delivery model of oral HIV pre- and post-exposure prophylaxis in Kenya: a pilot study extension.
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26467. doi: 10.1002/jia2.26467.
9
How plausible is it that PEP would be cost-effective in sub-Saharan Africa?
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26455. doi: 10.1002/jia2.26455.
10
Untapped potential of post-exposure prophylaxis in sub-Saharan Africa: a comparative analysis of PEP implementation planning in Kenya, Mozambique, Nigeria, Uganda and Zambia.
J Int AIDS Soc. 2025 Jun;28 Suppl 1:e26471. doi: 10.1002/jia2.26471.
Zotero 插件